AccessGUDID - DEVICE: reSET-O™ (10851580008057)

GUDID

Device Identifier (DI) Information

Brand Name: reSET-O™
Version or Model: 1.1
Commercial Distribution Status: Not in Commercial Distribution
Catalog Number: N/A
Company Name: PEAR THERAPEUTICS, INC.

Primary DI Number: 10851580008057
Issuing Agency: GS1
Commercial Distribution End Date: December 03, 2019
Device Count: 1
Labeler D-U-N-S® Number*: 079705123 *Terms of Use

Device Description: reSET-O Mobile Application runs on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application. Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

Device Characteristics

What MRI safety information does the labeling contain?	Labeling does not contain MRI Safety Information
Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437):	No
Device labeled as "Not made with natural rubber latex":	No
For Single-Use:	No
Prescription Use (Rx):	Yes
Over the Counter (OTC):	No
Kit:	No
Combination Product:	No
Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P):	No

GMDN

[?]

GMDN Term Code	GMDN Term Name	GMDN Term Definition	GMDN Term Status [?]	Implantable?
63031	Mental health/function therapeutic software, screen-viewed	A screen-based (non-virtual-reality) software program intended to be used with an off-the-shelf computer/smart device to help improve mental health/wellbeing (e.g., control effects of mood disorders, stress) and/or a cognitive function (e.g., concentration, memory, eye movement training to improve reading) by providing a patient with on-screen interactive sessions. It may additionally be designed to assess cognition/mental health, set baselines, help manage pain, and will typically indicate development (i.e., interactive). It is not intended for kinesiology-based neuromuscular rehabilitation. It is intended to be used by the patient which may involve clinical assistance/recommendations.	Active	false

FDA Product Code

[?]

Product Code	Product Code Name
PWE	Cognitive Behavioral Therapy Device For Psychiatric Disorders

FDA Premarket Submission

FDA Premarket Submission Number [?]	Supplement Number [?]
K173681	000

Device Exempt from Premarket Submission: No CLOSE

Sterilization

Device Packaged as Sterile: No
Requires Sterilization Prior to Use: No

Sterilization Method [?]
No Sterilization Methods Found

Storage and Handling

[?]

Storage and Handling
No storage/handling found

Clinically Relevant Size

[?]

Size Type Text
No Device Sizes

Device Record Status

Public Device Record Key: 3afad97c-0fb7-49b6-b0f8-94d2d36c81fa
Public Version Date: August 03, 2023
Public Version Number: 6
DI Record Publish Date: December 26, 2018